FindTrial
Sign In

Ki-67 labelling index is related to the risk classification and prognosis of gastrointestinal stromal tumours: a retrospective study

Ki-67 labelling index is related to the risk classification and prognosis of gastrointestinal stromal tumours: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026030
Enrollment
Unknown
Registered
2019-09-18
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal stromal tumours

Interventions

extremely low risk group, low risk group, medium risk group and high risk group:N/A

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients were radically resected by endoscopy or surgery and clearly diagnosed by pathology; 2.Primary GISTs; 3.Complete clinicopathology data.

Exclusion criteria

Exclusion criteria: 1. No surgical treatment or new adjuvant therapy before surgery; 2. Recurrence GISTs; 3. History of malignant tumors or other malignant tumors at the same time.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;Risk classification;Ki-67 labeling index;Clinicopathologic features;—

Countries

China

Contacts

Public ContactJun Lin

Zhongnan Hospital of Wuhan University

linjun6412@126.com+86 13971156723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026